During the past decade, MEDIVASA s r o conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MEDIVASA s r o" #1 sponsor was "Bayer" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MEDIVASA s r o" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "MEDIVASA s r o" are "Diabetes Mellitus, Type 2" (3 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "MEDIVASA s r o" in a lesser frequency.

Most popular intervention types in "MEDIVASA s r o" are "Drug" (14 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apabetalone" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "MEDIVASA s r o" are 15 trials for "All" genders.

Currently, there are NaN active trials in "MEDIVASA s r o". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in MEDIVASA s r o, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in MEDIVASA s r o, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".